|
|
||||||||
Institut National de la Santé et de la Recherche Médicale U460, 75018 Paris; and Institut National de la Santé et de la Recherche Médicale U397 and Physiology Department, Faculty of Medicine, 31054 Toulouse, France
Angiotensin II
(ANG II) produces vasoconstriction by a direct action on smooth muscle
cells via AT1 receptors. These
receptors are also present in the endothelium, but their function is
poorly understood. This study was therefore undertaken to determine
whether ANG II elicits the release of nitric oxide (NO) from cultured rat aortic endothelial cells. NO production, measured by the
accumulation of nitrite and nitrate, was enhanced by
10
7 M ANG II. The
biological activity of the NO released by ANG II action was evaluated
by measuring its guanylate cyclase-stimulating activity in smooth
muscle cells. The guanosine 3',5'-cyclic monophosphate (cGMP) content of smooth muscle cells was significantly increased by
exposure of supernatant from ANG II-stimulated endothelial cells. These
effects resulted from the activation of NO synthase, as they were
inhibited by the L-arginine
analogs. These ANG II actions were mediated by the
AT1 receptor, as shown by their
inhibition by the AT1 antagonist
losartan. The cGMP production by reporter cells was inhibited by the
calmodulin antagonist W-7, suggesting that ANG II activates endothelial
calmodulin-dependent NO synthase. This hypothesis is also supported by
the increase of intracellular free calcium induced by ANG II in
endothelial cells. ANG II also stimulated luminol-enhanced
chemiluminescence in endothelial cells. This effect was inhibited by
N
-monomethyl-L-arginine and
superoxide dismutase, suggesting that this luminol-enhanced
chemiluminescence reflected an increase in peroxynitrite production.
Thus ANG II stimulates NO release from macrovascular endothelium, which
may modulate the direct vasoconstrictor effect of ANG II on smooth
muscle cells. However, this beneficial effect may be counteracted by
the simultaneous production of peroxynitrite, which could contribute to
several pathological processes in the vascular wall.
nitric oxide synthase; guanosine 3',5'-cyclic monophosphate; intracellular free calcium; smooth muscle cells
This article has been cited by other articles:
![]() |
S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Zhang, Y. Nagai, T. Nakagawa, H. Miyanaka, Y. Fujisawa, A. Nishiyama, K. Izuishi, K. Ohmori, and S. Kimura Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2403 - H2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Daubert, D. Liu, I. H. Zucker, and V. L. Brooks Roles of nitric oxide and angiotensin II in the impaired baroreflex gain of pregnancy Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2179 - R2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zemse, R. H. P. Hilgers, and R. C. Webb Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Siddiqui and T. Hussain Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1722 - H1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. V. de Cavanagh, J. E. Toblli, L. Ferder, B. Piotrkowski, I. Stella, and F. Inserra Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1616 - R1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bivol, O. B. Vagnes, and B. M. Iversen The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension Am J Physiol Renal Physiol, August 1, 2005; 289(2): F393 - F400. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishimura, Y. Yang, C. Hubert, J.-M. Gasc, K. Ruijtenbeek, J. De Mey, H. A. J. S. Boudier, and P. Corvol Maturation-dependent changes of angiotensin receptor expression in fowl Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R231 - R242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rhinehart, C. A. Handelsman, E. P. Silldorff, and T. L. Pallone ANG II AT2 receptor modulates AT1 receptor-mediated descending vasa recta endothelial Ca2+ signaling Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H779 - H789. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moreno, A. Lopez, M. T. Llinas, F. Rodriguez, A. Lopez-Farre, E. Nava, and F. J. Salazar Changes in NOS activity and protein expression during acute and prolonged ANG II administration Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R31 - R37. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oelze, H. Mollnau, N. Hoffmann, A. Warnholtz, M. Bodenschatz, A. Smolenski, U. Walter, M. Skatchkov, T. Meinertz, and T. Munzel Vasodilator-Stimulated Phosphoprotein Serine 239 Phosphorylation as a Sensitive Monitor of Defective Nitric Oxide/cGMP Signaling and Endothelial Dysfunction Circ. Res., November 24, 2000; 87(11): 999 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishimura, T. Ito, J. M. Saavedra, and K. Sandberg Angiotensin II AT1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive Rats Editorial Comment Stroke, October 1, 2000; 31(10): 2478 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Linz, H. Heitsch, B. A. Scholkens, and G. Wiemer Long-Term Angiotensin II Type 1 Receptor Blockade With Fonsartan Doubles Lifespan of Hypertensive Rats Hypertension, April 1, 2000; 35(4): 908 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. WATTANAPITAYAKUL, D. M. WEINSTEIN, B. J. HOLYCROSS, and J. A. BAUER Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders FASEB J, February 1, 2000; 14(2): 271 - 278. [Abstract] [Full Text] |
||||
![]() |
A. A. Ogonowski, W. H. Kaesemeyer, L. Jin, V. Ganapathy, F. H. Leibach, and R. W. Caldwell Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production Am J Physiol Cell Physiol, January 1, 2000; 278(1): C136 - C143. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. CORDELIER, J.-P. ESTÈVE, N. RIVARD, M. MARLETTA, N. VAYSSE, C. SUSINI, and L. BUSCAIL The activation of neuronal NO synthase is mediated by G-protein {beta}{gamma} subunit and the tyrosine phosphatase SHP-2 FASEB J, November 1, 1999; 13(14): 2037 - 2050. [Abstract] [Full Text] |
||||
![]() |
S. Y. Chin, K. N. Pandey, S.-J. Shi, H. Kobori, C. Moreno, and L. G. Navar Increased activity and expression of Ca2+-dependent NOS in renal cortex of ANG II-infused hypertensive rats Am J Physiol Renal Physiol, November 1, 1999; 277(5): F797 - F804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Haas, J. D. Krier, R. J. Bolterman, L. A. Juncos, and J. C. Romero Low-Dose Angiotensin II Increases Free Isoprostane Levels in Plasma Hypertension, October 1, 1999; 34(4): 983 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Nowicki Effects of sustained low-flow perfusion on the response to vasoconstrictor agents in postnatal intestine Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1408 - G1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu and I. H. Zucker Regulation of Sympathetic Nerve Activity in Heart Failure : A Role for Nitric Oxide and Angiotensin II Circ. Res., March 5, 1999; 84(4): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. A. Blezer, K. Nicolay, P. R. D. Bar, R. Goldschmeding, G. H. Jansen, H. A. Koomans, J. A. Joles, and F. M. Faraci Enalapril Prevents Imminent and Reduces Manifest Cerebral Edema in Stroke-Prone Hypertensive Rats • Editorial Comment Stroke, August 1, 1998; 29(8): 1671 - 1678. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |